Skip to main content
All lobbying clients

BIOMERIEUX, INC.

Lobbying client · Utah · filed 2025 to 2026

Global in vitro diagnostics company.

$310,000 Reported spend
6 Filings counted
1 Firms hired
5 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (68018), not by name.

 Firms hired 1
 Bills named in these filings 5
  • HR 5269
    RESULTS Act
    4 filings
  • S 2761
    RESULTS Act
    4 filings
  • HR 1
    An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
    2 filings
  • HR 3164
    Ensuring Community Access to Pharmacist Services Act
    1 filing
  • S 2426
    Equitable Community Access to Pharmacist Services Act
    1 filing
 Reported by year 2 years
  • 2026 $140,000 2 filings
  • 2025 $170,000 4 filings
 Issues lobbied 7

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 4
  • HOUSE OF REPRESENTATIVES 5
  • SENATE 5
  • Centers For Medicare and Medicaid Services (CMS) 3
  • Health & Human Services, Dept of (HHS) 3
 Foreign entities disclosed 1
  • BIOMERIEUX, S.A. France named on 1 filing · highest disclosed ownership 100% · largest disclosed contribution $0

Section 7 of the LD-2: a foreign company or government that owns part of the client, pays toward the lobbying, or benefits from it. Figures are the highest single disclosure across these filings, not a sum: the same stake is re-disclosed each quarter.

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem